TY - JOUR
T1 - Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia
AU - Tiloca, Cinzia
AU - Ticozzi, Nicola
AU - Pensato, Viviana
AU - Corrado, Lucia
AU - Del Bo, Roberto
AU - Bertolin, Cinzia
AU - Fenoglio, Chiara
AU - Gagliardi, Stella
AU - Calini, Daniela
AU - Lauria, Giuseppe
AU - Castellotti, Barbara
AU - Bagarotti, Alessandra
AU - Corti, Stefania
AU - Galimberti, Daniela
AU - Cagnin, Annachiara
AU - Gabelli, Carlo
AU - Ranieri, Michela
AU - Ceroni, Mauro
AU - Siciliano, Gabriele
AU - Mazzini, Letizia
AU - Cereda, Cristina
AU - Scarpini, Elio
AU - Sorarù, Gianni
AU - Comi, Giacomo P.
AU - D'Alfonso, Sandra
AU - Gellera, Cinzia
AU - Ratti, Antonia
AU - Landers, John E.
AU - Silani, Vincenzo
N1 - Funding Information:
This research was supported by AriSLA (EXOMEFALS project 2009) and cofinanced with the support of “5 x 1000”-Healthcare Research of the Ministry of Health, Fondazione Cariplo (Grant, 2010-0728 ). Grant support was provided by the NIH/NINDS to J.E.L. ( 1R01NS065847 ). A.B. was supported by a fellowship "Amico Canobio" Association . We thank Dr Cecilia Carlesi for her contribution to clinical data.
PY - 2013/5
Y1 - 2013/5
N2 - Mutations in the profilin 1 (PFN1) gene, encoding a protein regulating filamentous actin growth through its binding to monomeric G-actin, have been recently identified in familial amyotrophic lateral sclerosis (ALS). Functional studies performed on ALS-associated PFN1 mutants demonstrated aggregation propensity, alterations in growth cone, and cytoskeletal dynamics. Previous screening of PFN1 gene in sporadic ALS (SALS) cases led to the identification of the p.E117G mutation, which is likely to represent a less pathogenic variant according to both frequency data in control subjects and cases, and functional experiments. To determine the effective contribution of PFN1 mutations in SALS, we analyzed a large cohort of 1168 Italian SALS patients and also included 203 frontotemporal dementia (FTD) cases because of the great overlap between these 2 neurodegenerative diseases. We detected the p.E117G variant in 1 SALS patient and the novel synonymous change p.G15G in another patient, but none in a panel of 1512 control subjects. Our results suggest that PFN1 mutations in sporadic ALS and in FTD are rare, at least in the Italian population.
AB - Mutations in the profilin 1 (PFN1) gene, encoding a protein regulating filamentous actin growth through its binding to monomeric G-actin, have been recently identified in familial amyotrophic lateral sclerosis (ALS). Functional studies performed on ALS-associated PFN1 mutants demonstrated aggregation propensity, alterations in growth cone, and cytoskeletal dynamics. Previous screening of PFN1 gene in sporadic ALS (SALS) cases led to the identification of the p.E117G mutation, which is likely to represent a less pathogenic variant according to both frequency data in control subjects and cases, and functional experiments. To determine the effective contribution of PFN1 mutations in SALS, we analyzed a large cohort of 1168 Italian SALS patients and also included 203 frontotemporal dementia (FTD) cases because of the great overlap between these 2 neurodegenerative diseases. We detected the p.E117G variant in 1 SALS patient and the novel synonymous change p.G15G in another patient, but none in a panel of 1512 control subjects. Our results suggest that PFN1 mutations in sporadic ALS and in FTD are rare, at least in the Italian population.
KW - Amyotrophic lateral sclerosis
KW - Frontotemporal dementia
KW - Mutation analysis
KW - Profilin 1
UR - http://www.scopus.com/inward/record.url?scp=84873434999&partnerID=8YFLogxK
U2 - 10.1016/j.neurobiolaging.2012.09.016
DO - 10.1016/j.neurobiolaging.2012.09.016
M3 - Article
SN - 0197-4580
VL - 34
SP - 1517.e9-1517.e10
JO - Neurobiology of Aging
JF - Neurobiology of Aging
IS - 5
ER -